Immunological markers of rheumatoid arthritis
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2016, Vol 70, Issue
Abstract
Rheumatoid arthritis (RA) is the most common connective tissue disease of autoimmune origin. The disease is characterized by chronic inflammation leading to bone erosions and organ involvement. RA is a progressive disease. It affects the quality of life, leading to disability and death mainly due to premature cardiovascular disease. Early diagnosis and appropriate treatment are essential for prognosis and quality of life improvement.In 2010 the American College of Rheumatology (ACR) and The European League Against Rheumatism (EULAR) established new RA classification criteria. Besides clinical symptoms it includes two immunologic criteria: rheumatoid factor (RF) and anti-citrullinated protein antibodies (anti-CCP antibodies). RF is the first well-known RA immunologic marker. It is observed in 80-85% of patients with RA. Elevated serum level of RF has been associated with increased disease activity, radiographic progression, and the presence of extraarticular manifestations. The sensitivity of RF is 50-90%, and specificity is 50-95%. Anti-CCP antibodies appear to be a more specific marker than RF. They are often present at the very beginning of the disease, or even years before the first symptoms. The prognostic value of anti-CCP antibodies is well established. High serum level of anti-CCP correlates with poor prognosis and early erosions of the joints. The sensitivity of anti-CCP2 is 48-80%, and specificity is 96-98%.New immunologic markers include anti-carbamylated protein antibodies (anti-CarP) and antibodies against heterogeneous nuclear ribonucleoproteins (anti-hnRNP A2/B1, RA33). Scientists aim to identify a highly sensitive and specific biomarker of the disease that not only has diagnostic and prognostic value but also may predict the response to treatment.
Authors and Affiliations
Agnieszka Matuszewska, Marta Madej, Piotr Wiland
Keywords
Related Articles
- EP ID EP220745
- DOI -
- Views 142
- Downloads 0
Potential therapeutic interventions via EP2/EP4 prostaglandin receptors
Prevention and treatment of pathological inflammatory processes requires application of various classes of immune suppressors, such as calcineurin inhibitors, steroids and non-steroid inhibitors of prostaglandin synthesi...
Mitochondria w niedotlenieniu mózgu
Neurony różnią się znacznie kształtem, rozmiarem, rodzajem neuroprzekaźników i liczbą tworzonych synaps. Ich wspólną cechą charakterystyczną jest bardzo duża wrażliwość na zmiany stężenia tlenu. Następstwem niedotlenieni...
Rola płytek krwi w zakażeniach
Płytki krwi są kojarzone z ich główną funkcją, tj. utrzymaniem prawidłowego przepływu krwi oraz procesem krzepnięcia, chociaż wiadomo, że wykazują również aktywność biologiczną w innych ważnych procesach, np. w rozwoju n...
Role of prometastatic factors in gastric cancer development
The second half of the 20th century has seen a sharp worldwide decline in both the incidence and mortality of gastric cancer. Despite this, gastric cancer is the most common cause of mortality in the world. It is closely...
Znaczenie badań farmakogenetycznych w efektywności leczenia metotreksatem chorych na reumatoidalne zapalenie stawów (część 2)
Obecnie dużą nadzieję wiąże się z indywidualizacją leczenia chorych na reumatoidalne zapalenie stawów (RZS). Trwają poszukiwania markerów biochemicznych i klinicznych, dzięki którym można by przewidzieć dobrą odpowiedź...